Navigation Links
Foamix Ltd. and Therapeutics Inc. Enter Into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases - Will Target Over 20 Million Psoriasis and Atopic Dermatitis Patients
Date:3/3/2010

roven track record of successfully marrying their proprietary and unique foam systems with dermatological drugs. Together we will develop unique Rx foams that can be readily applied to the sensitive skin of atopic dermatitis and psoriasis patients. These products will fill an unmet market need for convenient and elegant treatments of inflammatory skin diseases," said Daniel Piacquadio, M.D, President & CEO of Therapeutics Inc, as he announced the joint development agreement.

About Foamix

Foamix Ltd. is a leading developer of topical and mucosal foams for dermatological and gynecological applications. Foamix's state-of-the-art foams provide controlled delivery of a variety of active ingredients. Foamix is currently collaborating with pharmaceutical and cosmetic companies on a range of projects in the development of proprietary dermatological and gynecologic foam products. Additionally, the Company has an in-house pipeline of dermatological and gynecological formulations in foam presentation. Foamix's psoriasis foam product licensed to Dr. Reddy's Laboratories and marketed by Promius Pharma under the trade mark Scytera(TM) was launched in the United States in early 2009.

Foamix has nineteen issued patents worldwide covering its foam and OilGel technology platform
'/>"/>

SOURCE Foamix Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
2. Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
3. Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis
4. Foamix Receives US Patent on Novel Foam Technology
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
10. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
11. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 After the boom ... that the next beverage craze is going to be ... that formulators can use Stress Relief energy pattern which ... the making of a beverage, including minerals, herbs and ... energy, channeling that power into rapid recovery and helping ...
(Date:8/27/2014)... August 27, 2014 WriteResult, LLC – ... has once again shown superiority when it comes to ... completing the ePRO portion of their most recent study ... Japan-based pharma chose WriteResult’s digital writing platform to collect ... the first to complete drew data from a number ...
(Date:8/26/2014)...  NeuroSigma, Inc., a Los Angeles ... today announced that it has filed a registration statement ... Commission relating to a proposed initial public offering of ... offered and the price range for the proposed offering ... will act as the book-running manager for the proposed ...
(Date:8/26/2014)... August 26, 2014 The 20 ambassadors ... ALS (YFALS) community issued the following statement on Facebook ... awareness and driving new funding specifically for ALS research: ... water and some ice would raise all this awareness ... our families, and on behalf of the entire ALS ...
Breaking Biology Technology:Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4
... Peterson, president and CEO of ZyStor Therapeutics, Inc. ... for attendees of this year's Midwestern bioscience forum. , ... Wisconsin biotechnology companies with another presenter, Dr. Irene Hrusovsky, ... of molecular diagnostic products. , ,Like many of the ...
... engine optimization (SEO) tactics have one thing in common: ... and incorporating them into a web site, marketers can ... a desirable search engine ranking requires good information about ... website's industry or topic. A good place to start ...
... - CDW Corp. , a $6 billion-a-year information technology ... agreed to acquire the stock of Madison-based Berbee Information ... ,The acquisition, which has been approved by the boards of ... October, subject to regulatory approvals and approval by Berbee shareholders. ...
Cached Biology Technology:ZyStor to exhibit cell disorder treatments 2Search engine optimization: What's the word? 2Search engine optimization: What's the word? 3Berbee believes acquisition by CDW will make it a national IT player 2Berbee believes acquisition by CDW will make it a national IT player 3
(Date:8/27/2014)... a group of fish began exploring land and evolved into ... how these ancient fish used their fishy bodies and fins ... play remain scientific mysteries. , Researchers at McGill University ... living fish, called Polypterus , to help show what ... of the water. Polypterus is an African fish ...
(Date:8/27/2014)... An invasive grass species frequently found in forests has ... feed on American toads, a new University of Georgia ... introduced to the U.S. in the early 1900s, is ... spread to more than a dozen states in the ... roads and in forests, it can survive in widely ...
(Date:8/27/2014)... /PRNewswire-iReach/ -- The IEEE Engineering in Medicine and Biology ... International Conference (EMBC,14), this year being held at the ... Illinois , from Tuesday, August 26 through Saturday, ... industry professionals in science, medicine, and engineering are registered ... This year,s conference theme is ...
Breaking Biology News(10 mins):Walking fish reveal how our ancestors evolved onto land 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3
... a wide range of highly ordered structures that feature ... innovation inspired by nature humans hope to emulate ... A key to accomplishing this is understanding how protein-folding ... of a protein is extended from individual proteins ...
... October 31, 2012 Scientists at The Scripps ... of an important set of enzymes. The new inhibitors, ... used to study the functions of enzymes known as ... regulate. Early tests in mouse macrophages suggest that DAGL-inhibiting ...
... research discovery has the potential to revolutionize the biological ... found that when a single protein involved in brain ... the brain functioning of mice that cause symptoms that ... in children. Because this protein has similar functions in ...
Cached Biology News:Folding funnels key to biomimicry 2Folding funnels key to biomimicry 3New inhibitors of elusive enzymes promise to be valuable scientific tools 2New inhibitors of elusive enzymes promise to be valuable scientific tools 3Single protein targeted as the root biological cause of several childhood psychiatric disorders 2
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)...
... Phosphatase 2 (LPP2) fractionated ... solution Solution in ... 0.08% sodium azide. unique ... human LPP2 protein. The ...
Rabbit polyclonal to Retinoic Acid Receptor beta 2 ( Abpromise for all tested applications). entrezGeneID: 5915...
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Biology Products: